New concepts in heparin-induced thrombocytopenia: Diagnosis and management

Journal of Thrombosis and Thrombolysis

Volumn 21, Issue 1, 2006, Pages 17-21

  Spinler, Sarah A ^a,b  

^a UNIVERSITY OF THE SCIENCES   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Fondaparinux; Heparin induced thrombocytopenia; Thrombocytopenia

Indexed keywords

ANTICOAGULANT AGENT; ARGATROBAN; FIBRINOGEN RECEPTOR ANTAGONIST; FONDAPARINUX; HEPARIN; HIRULOG; LEPIRUDIN; LOW MOLECULAR WEIGHT HEPARIN; PROSTACYCLIN; THROMBIN INHIBITOR; TIROFIBAN; WARFARIN;

AGGLUTINATION TEST; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; CLINICAL TRIAL; CROSS REACTION; DEEP VEIN THROMBOSIS; DRUG CHOICE; DRUG COST; DRUG SUBSTITUTION; ENZYME IMMUNOASSAY; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; IN VITRO STUDY; LUNG EMBOLISM; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; SINGLE DRUG DOSE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGLUTINATION; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; CLINICAL TRIALS; HEPARIN; HUMANS; POLYSACCHARIDES; THROMBOCYTOPENIA; THROMBOEMBOLISM;

EID: 32544446868     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-006-5571-z     Document Type: Review

References (27)

1. Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia: recognition, treatment, and prevention: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126(3 Suppl):311S-337S.
2. Refaai MA, Van Cott EM, Laposata M. The timing of a positive test result for heparin-induced thrombocytopenia relative to the platelet count and anticoagulant therapy in 43 consecutive cases. Am J Clin Pathol 2003;119:497-504.
3. Warkentin TE. New approaches to the diagnosis of heparin-induced thrombocytopenia. Chest 2005;127(2 Suppl):35S-45S.
4. Kelton JG. The pathophysiology of heparin-induced thrombocytopenia: biological basis for treatment. Chest 2005:127(2 Suppl):9S-20S.
5. Rice L. Heparin-induced thrombocytopenia: Myths and misconceptions (that will cause trouble for you and your patient). Arch Intern Med 2004;164:1961-1964.
6. Warkentin TE, Kelton JG. Delayed-onset heparin-induced thrombocytopenia and thrombosis. Ann Intern Med 2001;135:502-506.
7. Rice L, Attisha WK, Drexler A, Francis JL. Delayed-onset heparin-induced thrombocytopenia. Ann Intern Med 2002;136:210-215.
8. Shah MR, Spencer JP. Heparin-induced thrombocytopenia occurring after discontinuation of heparin. J Am Board Fam Pract 2003;16:148-150.
9. Warkentin TE, Bernstein RA. Delayed-onset heparin-induced thrombocytopenia and cerebral thrombosis after a single administration of unfractionated heparin (Letter). N Engl J Med 2003;348:1067-1069.
10. Smythe MA, Stephens JL, Mattson JC. Delayed-onset heparin-induced thrombocytopenia. Ann Emerg Med 2005;45:417-19.
11. Hassell K. The management of patients with heparin-induced thrombocytopenia who require anticoagulant therapy. Chest 2005;127(2 Suppl):1S-8S.
12. Spinler SA, Dagar W. Overview of heparin-induced thrombocytopenia. Am J Health Syst Pharm 2003;60 (Suppl 5):S5-11.
13. ARIXTRA (fondaparinux sodium) Inection Prescribing Information. GlaxoSmithKline, Research Triangle Park, MC; May 2005.
14. Savi P, Chong BH, Greinacher A, et al. Effect of fondaparinux on platelet activation in the presence of heparin-dependent antibodies: A blinded comparative multicenter study with unfractionated heparin. Blood 2005;105:139-144.
15. Greinacher A, Alban S, Dummel V, Franz G, Mueller-Eckhardt C. Characterization of the structural requirements for a carbohydrate based anticoagulant with a reduced risk of inducing the immunological type of heparin-associated thrombocytopenia. Thromb Haemost 1995;74(3):886-892.
16. Elalamy I, Lecrubier C, Potevin F, et al. Absence of in vitro cross-reaction of pentasaccharide with the plasma heparin-dependent factor of twenty-five patients with heparin-associated thrombocytopenia. Thromb Haemost 1995;74(5):1384-1385.
17. Amiral J, Lormeau JC, Marfaing-Koka A, et al.Absence of cross-reactivity of SR90107A/ORG31540 pentasaccharide with antibodies to heparin-PF4 complexes developed in heparin-induced thrombocytopenia. Blood Coagul Fibrinolysis 1997;8(2):114-117.
18. Ahmad S, Jeske WP, Walenga JM, et al. Synthetic pentasaccharides do not cause platelet activation by antiheparin-platelet factor 4 antibodies. Clin Appl Thromb Hemost 1999;5(4):259-266.
19. Harenberg J, Jorg I, Fenyvesi T, Hagedorn A, Giese C, Trager I. Prophylaxsi of recurrent thromboembolism in a patient with a history of heparin-induced thrombocytopenia with thrombosis, anti-lepirudin antibodies after Bjork-Shiley aortic valve implantation using fondaparinux. J Thrombos Haemost 2003(Suppl 1): Abstract P2040.
20. D'Amico EA, Villaca PR, Gualandro FM, Bassitt RP, Chamone DAF. Successful use of Arixtra in a patients with paroxysmal nocturnal hemoglobinuria, Budd-Chiari syndrome and heparin-induced thrombocytopenia. J Thrombos Haemost 2003;1:2452-2453.
21. Lian EC, Chua L, Oberstein E. Long-term use of fondaparinux in a patients with antiphospholipid antibody sudrome, heparin-induced thrombocytopenia and regractoriness to coumarin (abstract). Blood 2003;102:4206.
22. Bradner J, Hallisey RK, Kuter DJ. Fondaparinux in the treatment of heparin-induced thrombocytopenia (abstract). Blood 2004;104(11):ABstract 4072.
23. Kuo KHM, Kovacs MJ. Successful treatment of heparin induced thrombocytopenia (HIT) with fondaparinux (abstract). Blood 2003;102:1147.
24. Rubin N, Rubin J. Treatment of heparin-induced thrombocytopenia with thrombosis (HITT) in pregnancy with fondaparinux (abstract). Blood 2003;102:4190.
25. Parody R, Oliver A, Souto JC, Fontcuberta J. Fondaparinux (ARIXTRA) as an alternative anti-thrombotic prophylaxis when there is hypersensitivity to low molecular weight and unfractionated heparins. Hematologica 2003;88(110):ECR32.
26. Haase M, Ellomo R, Rocktaeschel J, et al. Use of fondaparinux (ARIXTRA) in a dialysis patient with symptomatic heparin-induced thrombocytopenia type II. Nephrol Dial Transplant 2005;20:444-446.
27. Kovacs MJ. Successful treatment of heparin-induced thrombocytopenia (HIT) with fondaparinux. Thromb Haemost 2005;93:999-1000.